R&D, Pharmacovigilance & Regulatory Affairs_tr

Ar-Ge, Farmakovijilans ve Ruhsatlandırma İşleri

Yeni ilaç çözümleri araştırma, geliştirme, test etme ve piyasaya sürme. Geliştirme süreci 8 ila 10 yıl sürer ve 4 fazdan oluşur.

  • Ar-Ge, Farmakovijilans ve Ruhsatlandırma İşleri

    Yeni ilaç çözümleri araştırma, geliştirme, test etme ve piyasaya sürme. Geliştirme süreci 8 ila 10 yıl sürer ve 4 fazdan oluşur.

Başlık Konum Tarih Sort descending Req ID
Sıfırla
Translational and Precision Medicine Lead 1
Translational and Precision Medicine Lead 1 Europe - remote, GB 16 Nis 2026 7208
Europe - remote, GB 16 Nis 2026 7208
Senior Director, Clinical Excellence AIR - Bronchiectasis & Non-obstructive Lung Diseases Europe, IT 15 Nis 2026 6111
INTERN - Clinical Supply Management & Distribution Parma, IT 14 Nis 2026 7186
Master's thesis in computational modelling of aerosol deposition in respiratory system Parma, IT 11 Nis 2026 6598
Clinical Program Leader
Clinical Program Leader Cary, NC, US 11 Nis 2026 7017
Cary, NC, US 11 Nis 2026 7017
Senior Director, Clinical Biometrics & Analytics Parma, IT 11 Nis 2026 6387
Senior Manager, CMC Regulatory Affairs, Global Rare Diseases Europe, IT 9 Nis 2026 6592
Pharmazeut (all genders) im Praktikum für 2026 / 2027 Hamburg, DE 5 Nis 2026 351
INTERN - Patient Engagement
INTERN - Patient Engagement PARMA, IT 28 Mar 2026 5993
PARMA, IT 28 Mar 2026 5993
Medical Information & PV Officer
Medical Information & PV Officer Zaventem (BE) or Schiphol (NL), BE 25 Mar 2026 7089
Zaventem (BE) or Schiphol (NL), BE 25 Mar 2026 7089
Clinical Research Physician, Rare Disease
Clinical Research Physician, Rare Disease Europe - remote, IT 23 Mar 2026 7087
Europe - remote, IT 23 Mar 2026 7087